# A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

> **NCT02692859** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 1992 (actual)

## Conditions studied

- Haemophilus Influenza

## Interventions

- **BIOLOGICAL:** Hib conjugate vaccine

## Key facts

- **NCT ID:** NCT02692859
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 1992 (ACTUAL)
- **Last updated:** 2017-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02692859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02692859, "A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02692859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*